CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3.72 Cr | ₹0.79 Cr | ₹1.66 Cr | ₹0.77 Cr |
What is the latest Cash Flow from Operating Activities ratio of CONCORD DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹3.72 Cr |
| Mar2024 | ₹0.79 Cr |
| Mar2023 | ₹1.66 Cr |
| Mar2022 | ₹0.77 Cr |
How is Cash Flow from Operating Activities of CONCORD DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.72 Cr | 369.95 | |
| Mar2024 | ₹0.79 Cr | -52.38 | |
| Mar2023 | ₹1.66 Cr | 114.86 | |
| Mar2022 | ₹0.77 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹101.7 Cr | -0.5% | 12.6% | 15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -0.5% |
12.6% |
15.7% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses